Travis Bond, Altoida - Technology to Predict Neurological Disease | LSI Europe '22

The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR). A proprietary artificial intelligence (AI) algorithm analyzes these findings to assess brain health and predict neurological disease development.
Speakers
Travis Bond
Travis Bond
CEO, Altoida